Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHRecruiting
NCT06528314Phase 3Updated Sep 8, 2026
Sponsor: Akero Therapeutics, Inc
NASH - Nonalcoholic Steatohepatitis · MASH - Metabolic Dysfunction-Associated Steatohepatitis
United States, Argentina, Australia, Brazil, Canada +15 more
A Study of LY3526318 in Healthy Male Japanese ParticipantsWithdrawn
NCT05580250Phase 1Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Healthy
Japan
Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast CarcinomasCompleted
NCT02794558NAUpdated Sep 8, 2026
Sponsor: InSightec
Breast Cancer
Japan
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneeRecruiting
NCT07153471Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Osteoarthritis
United States, Canada, China, Germany, Japan +2 more
Observational Study Protocol: LIVER-RRecruiting
NCT06252753N/AUpdated Sep 8, 2026
Sponsor: AstraZeneca
Hepatobiliary Cancers
United States, Australia, Austria, Belgium, Brazil +17 more
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Recruiting
NCT07221149Phase 2, Phase 3Updated Sep 8, 2026
Sponsor: Bristol-Myers Squibb
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +15 more
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung DiseaseRecruiting
NCT05878717Phase 2, Phase 3Updated Sep 8, 2026
Sponsor: GlaxoSmithKline
Systemic Sclerosis Associated Interstitial Lung Disease · Scleroderma, Systemic
United States, Argentina, Australia, Belgium, Brazil +13 more
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationRecruiting
NCT05789082Phase 1, Phase 2Updated Sep 8, 2026
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +13 more
Anti-GD2 ADC M3554 in Advanced Solid TumorsRecruiting
NCT06641908Phase 1Updated Sep 8, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumor
United States, Belgium, France, Japan, Switzerland +1 more
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)Active Not Recruiting
NCT07005128Phase 3Updated Sep 8, 2026
Sponsor: Amgen
Small-cell Lung Cancer · Extensive Stage Small-cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT06793215Phase 3Updated Sep 8, 2026
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer · KRAS G12C Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +23 more
A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenActive Not Recruiting
NCT07596199Phase 3Updated Sep 8, 2026
Sponsor: GlaxoSmithKline
Diphtheria-Tetanus-acellular Pertussis Vaccines
Japan
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary SyndromesRecruiting
NCT07102628Phase 3Updated Sep 8, 2026
Sponsor: Novartis Pharmaceuticals
Acute Coronary Syndrome
Argentina, Australia, Canada, China, France +9 more
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)Recruiting
NCT07545772Phase 2Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Irritable Bowel Syndrome · Constipation
United States, Belgium, Canada, China, Japan +3 more
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsActive Not Recruiting
NCT06625060Phase 2Updated Sep 8, 2026
Sponsor: Ipsen
Episodic Migraine · Chronic Migraine
United States, Australia, Brazil, Canada, Czechia +9 more
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary FibrosisRecruiting
NCT07201922Phase 3Updated Sep 8, 2026
Sponsor: Boehringer Ingelheim
Familial Pulmonary Fibrosis · Interstitial Lung Abnormalities · Interstitial Lung Diseases
United States, Argentina, Australia, Belgium, Canada +8 more
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerRecruiting
NCT07173751Phase 3Updated Sep 8, 2026
Sponsor: BioNTech SE
Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +11 more
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruiting
NCT06172478Phase 2Updated Sep 8, 2026
Sponsor: Daiichi Sankyo
Advanced Solid Tumor · Melanoma · Head and Neck Cancer · Gastric Cancer
United States, Australia, Belgium, Canada, China +11 more
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataRecruiting
NCT05723198Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Areata Alopecia · Alopecia · Hypotrichosis · Hair Diseases
United States, Argentina, Australia, Canada, France +7 more
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightRecruiting
NCT07353931Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Osteoarthritis · Overweight or Obesity
United States, Argentina, Belgium, Brazil, Canada +9 more
Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibActive Not Recruiting
NCT06531109N/AUpdated Sep 8, 2026
Sponsor: Pfizer
Alopecia Areata
United States, China, France, Italy, Japan +1 more
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsRecruiting
NCT06427941Phase 1, Phase 2Updated Sep 8, 2026
Sponsor: BeOne Medicines
Metastatic Hepatocellular Carcinoma · Local Advanced Hepatocellular Carcinoma · Alpha-fetoprotein (AFP)-Producing Gastric Cancer · Extragonadal Yolk Sac Tumors
United States, Brazil, China, France, Italy +4 more
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruiting
NCT07213804Phase 3Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Ovarian Neoplasms · Fallopian Tube Neoplasms · Peritoneal Neoplasms · Neoplasm Metastasis
United States, Australia, Austria, Belgium, Brazil +22 more
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Recruiting
NCT07589595Phase 2Updated Sep 8, 2026
Sponsor: Eli Lilly and Company
Cognitive Dysfunction · Lewy Body Disease · Synucleinopathies · Amyloid
United States, Japan, South Korea, Taiwan
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyRecruiting
NCT07218926Phase 3Updated Sep 8, 2026
Sponsor: GlaxoSmithKline
Gastrointestinal Neoplasms
United States, Australia, Belgium, Brazil, Canada +14 more

Previous page Next page